Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma

Bioscience Reports
Chunrong SongJing Guo

Abstract

Thymosin β 10 (TMSB10) has been demonstrated to be overexpressed and function as an oncogene in most types of human cancer including hepatocellular carcinoma (HCC). In our study, we present more evidence about the clinical significance and biological function of TMSB10 in HCC. First, we observed levels of TMSB10 expression were obviously increased in HCC tissues compared with normal liver tissues at The Cancer Genome Atlas (TCGA) datasets. Furthermore, we confirmed that TMSB10 mRNA and protein levels were also increased in HCC tissue samples compared with normal adjacent normal liver tissue samples. In addition, we found high TMSB10 expression was remarkably associated with the advanced tumor stage, large tumor size, distant metastasis, and poor prognosis, and acted as an independent factor for predicting poor overall survival in HCC patients. Loss-of-function studies suggested silencing of TMSB10 expression dramatically reduced cell proliferation, migration, and invasion in HCC. In conclusion, TMSB10 may hold promise as a tumor biomarker for predicting prognosis and a potential target for developing a novel therapeutic strategy.

References

Nov 1, 1996·British Journal of Cancer·S Verghese-NikolakakiG P Evangelatos
Sep 17, 1999·The American Journal of Pathology·G SantelliA Fusco
Jun 29, 2005·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Ingo AlldingerChristian Pilarsky
Jun 21, 2006·Histochemistry and Cell Biology·Aase Elisabeth MaelanLars-Inge Larsson
Sep 16, 2008·Human Pathology·Yumei GuEnhua Wang
May 10, 2011·Journal of Proteomics·William M HardestyRichard M Caprioli
Dec 14, 2011·Pathology Oncology Research : POR·Liliána Z FehérLászló G Puskás
Jan 17, 2013·Cancer Investigation·Sirinapa SribenjaChangyi Chen
Apr 8, 2014·European Journal of Histochemistry : EJH·W TheunissenG Faa
Jun 30, 2014·The Journal of Surgical Research·Xiao-Jun ZhangWen-Kuan Chen
Jul 20, 2014·World Journal of Surgical Oncology·Haoyuan WangMinshan Chen
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Feb 18, 2018·Journal of Gastrointestinal Cancer·Weijing Sun, Roniel Cabrera
Mar 6, 2018·Journal of Hepatology·Jean-Charles NaultJens U Marquardt
Aug 3, 2018·Current Chemical Genomics and Translational Medicine·Amit Kumar SinghAbhay K Pandey

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.